Incisional hernias post cytoreductive surgery/peritonectomy and hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis

[11] Bhatt A(2008)Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 754-43

[12] Glehen O(2010)Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy World J Gastrointest Oncol 2 36-260

[13] Sparks DS(2006)The management of incisional hernia Ann R Coll Surg Engl 88 252-771

[14] Morris B(2016)Cancer survivorship: defining the incidence of incisional hernia after resection for intra-abdominal malignancy Ann Surg Oncol 23 764-1523

[15] Xu W(2021)Incidence and risk factors for incisional hernia and recurrence: retrospective analysis of the French national database Colorectal Dis 23 1515-327

[16] Fulton J(2015)Systematic review and meta-regression of factors affecting midline incisional hernia rates: analysis of 14,618 patients PLoS One 10 e0138745-907

[17] Atkinson V(2015)Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge J Surg Oncol 111 324-10

[18] Meade B(2009)Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality Ann Surg 249 900-298

[19] Lutton N(2018)Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study World J Surg Oncol 16 1-815

[20] McConnell YJ(2017)Abdominal wall morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Scand J Surg 106 294-893

[11] Bhatt A(2008)Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 754-43

[12] Glehen O(2010)Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy World J Gastrointest Oncol 2 36-260

[13] Sparks DS(2006)The management of incisional hernia Ann R Coll Surg Engl 88 252-771

[14] Morris B(2016)Cancer survivorship: defining the incidence of incisional hernia after resection for intra-abdominal malignancy Ann Surg Oncol 23 764-1523

[15] Xu W(2021)Incidence and risk factors for incisional hernia and recurrence: retrospective analysis of the French national database Colorectal Dis 23 1515-327

[16] Fulton J(2015)Systematic review and meta-regression of factors affecting midline incisional hernia rates: analysis of 14,618 patients PLoS One 10 e0138745-907

[17] Atkinson V(2015)Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge J Surg Oncol 111 324-10

[18] Meade B(2009)Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality Ann Surg 249 900-298

[19] Lutton N(2018)Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study World J Surg Oncol 16 1-815

[20] McConnell YJ(2017)Abdominal wall morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Scand J Surg 106 294-893